In8Bio (INAB) Other Accumulated Expenses (2020 - 2026)
In8Bio's Other Accumulated Expenses came in at $21,000 for Q2 2026, down 64.4% from $59,000 a year earlier and down 61.8% from the prior quarter.
Powered by 
Analysis
In8Bio (INAB) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
At the end of FY2025, In8Bio's Other Accumulated Expenses was $63,000, down 51.9% from FY2024.
- Other Accumulated Expenses has declined in each of the last three years, with a five-year compound annual growth rate of -30.9% (FY2020 to FY2025).
- Going back by year, Other Accumulated Expenses was $131,000 in FY2024 (-63.5%), $359,000 in FY2023 (-14.1%), $418,000 in FY2022 (+719.6%) and $51,000 in FY2021 (-87.3%).
- The five-year range for quarterly Other Accumulated Expenses is $5,000 (Q3 2025) to $1.09 million (Q3 2022).
- Year-over-year, Other Accumulated Expenses has declined for five consecutive quarters, with an average decline of 57.6% over the last eight quarters.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q4 2022 (growth of 719.6%), and the weakest in Q3 2025 (a decline of 96.5%).
- Business Quant data shows INAB's Other Accumulated Expenses at $55,000 (Q1 2026), $63,000 (Q4 2025) and $5,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | In8Bio | 27.25 Mn | 27.25 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21,000.00 |
| Mar 31, 2026 | 55,000.00 |
| Dec 31, 2025 | 63,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 59,000.00 |
| Mar 31, 2025 | 230,000.00 |
| Dec 31, 2024 | 131,000.00 |
| Sep 30, 2024 | 142,000.00 |
| Jun 30, 2024 | 281,000.00 |
| Mar 31, 2024 | 183,000.00 |
| Dec 31, 2023 | 359,000.00 |
| Sep 30, 2023 | 319,000.00 |
| Jun 30, 2023 | 386,000.00 |
| Mar 31, 2023 | 407,000.00 |
| Dec 31, 2022 | 418,000.00 |
| Sep 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 696,000.00 |
| Mar 31, 2022 | 360,000.00 |
| Dec 31, 2021 | 51,000.00 |
| Sep 30, 2021 | 474,000.00 |
API Access
In8Bio Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=INAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "INAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=INAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();